there are a couple main problems with Atomo
1) they are very obscure re their finances (we still 'lost' a couple million from a year ago... it was sold in one Q, but the cash never, ever came in); so, in short, Atomo will never be able to be rated on fundamentals, since they dont tell you any detail
2) they seem to have great product (according to them) but they cannot sell much; my opinion (I wrote before) is that for political reasons they are financially hamstrung; people 'should' be able to prove antibodies as a method to get their vax passport, but govts (controlled by some shadowy figures) will not allow this; that is why the antibody test is a big fail - for political reasons; also, I do worry their saleman are very poor; mind you if Joe Hockey cannot sell any, then maybe the product is overhyped; more politically, the cheaper the product (not Atomo) the better; govts are all about bum covering and looking after mates... so you have big pharma and big labs being looked after, then to back fill govts will just choose the cheapest bit of rubbish to cover their bums; Atomo is in the middle ground... as good and cheaper than big pharma and labs... but dearer (and better) than cheapo bits in a box
The summary of my point 2 is: for political reasons Atomo could fail to develop as they should as a business; I hate when politics directs (for sinister reasons) the profitability (or not) of good companies
- Forums
- ASX - By Stock
- AT1
- Media Update
AT1
atomo diagnostics limited
Add to My Watchlist
0.00%
!
1.4¢

Media Update, page-1084
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $10.31M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 3821439 | 1.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.5¢ | 1397440 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 3636439 | 0.014 |
8 | 1239260 | 0.013 |
5 | 605833 | 0.012 |
3 | 618725 | 0.011 |
6 | 4120000 | 0.010 |
Price($) | Vol. | No. |
---|---|---|
0.015 | 599940 | 3 |
0.016 | 1095924 | 4 |
0.017 | 1289350 | 7 |
0.018 | 686654 | 5 |
0.019 | 156750 | 4 |
Last trade - 16.21pm 04/07/2025 (20 minute delay) ? |
Featured News
AT1 (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online